MPM BioImpact’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-267,557
| Closed | -$5.5M | – | 51 |
|
|
2024
Q3 | $5.5M | Sell |
267,557
-175,946
| -40% | -$3.62M | 0.82% | 32 |
|
|
2024
Q2 | $9.93M | Buy |
443,503
+10,905
| +3% | +$244K | 1.54% | 24 |
|
|
2024
Q1 | $11.9M | Buy |
432,598
+50,000
| +13% | +$1.38M | 1.91% | 17 |
|
|
2023
Q4 | $11.7M | Sell |
382,598
-162,041
| -30% | -$4.94M | 2.73% | 13 |
|
|
2023
Q3 | $17.2M | Hold |
544,639
| – | – | 4.6% | 6 |
|
|
2023
Q2 | $22.2M | Sell |
544,639
-27,820
| -5% | -$1.13M | 4.47% | 7 |
|
|
2023
Q1 | $21.3M | Buy |
572,459
+117,221
| +26% | +$4.37M | 5.54% | 6 |
|
|
2022
Q4 | $15.9M | Buy |
455,238
+80,829
| +22% | +$2.82M | 4.12% | 8 |
|
|
2022
Q3 | $21M | Buy |
374,409
+75,000
| +25% | +$4.2M | 4.96% | 5 |
|
|
2022
Q2 | $15.5M | Buy |
299,409
+140,000
| +88% | +$7.25M | 4.3% | 5 |
|
|
2022
Q1 | $11.6M | Sell |
159,409
-1,118
| -0.7% | -$81.2K | 3.11% | 6 |
|
|
2021
Q4 | $19M | Sell |
160,527
-2,093
| -1% | -$247K | 3.46% | 8 |
|
|
2021
Q3 | $21.8M | Buy |
+162,620
| New | +$21.8M | 3.38% | 9 |
|